AMYRIS, INC.

Amyris, Inc. specializes in applied biotechnology research and development, focusing on the design and engineering of microbial systems for sustainable chemical production. Their core capabilities center on synthetic biology platforms, metabolic pathway optimization, and fermentation process development, leveraging strain engineering and high-throughput screening to deliver bio-based alternatives to petroleum-derived compounds. The company applies precision genetic tools and computational modeling to accelerate the translation of biological innovations into scalable industrial processes, with particular expertise in yeast and bacterial chassis development for non-pharmaceutical applications. Their technical differentiation lies in integrating systems biology with industrial biomanufacturing to solve complex supply chain challenges through biological solutions. Amyris has delivered research and development services to the Department of Defense, where their work supports mission-critical needs in bio-based materials, energy-dense compounds, and sustainable feedstocks for defense applications. The nature of the engagement suggests collaboration on advanced bioproduction initiatives aligned with military logistics and resilience goals, indicating a focused partnership in securing next-generation biological technologies for national security use cases. The company’s primary industry focus is in research and development within biotechnology, specifically non-nanobiotechnology applications. This encompasses the engineering of biological systems for chemical, material, and energy applications outside of pharmaceuticals or diagnostics. Amyris positions itself at the intersection of life sciences and industrial manufacturing, serving markets demanding renewable, high-performance alternatives to traditional petrochemicals. Amyris, Inc. is a privately held entity headquartered in Emeryville, California. While the company does not hold any formal government certifications, its technical capabilities and R&D focus align it with federal innovation programs seeking advanced biomanufacturing solutions. Its geographic presence in the San Francisco Bay Area places it within a dense ecosystem of biotech innovation, enhancing its ability to attract interdisciplinary talent and collaborate with research institutions supporting government science priorities.